- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Top Stock Picks from Analysts
Hong Kong Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
14
Companies which are more than 50% undervalued based on analyst price target.
14 companies
Genscript Biotech
Market Cap: HK$26.8b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$12.30
7D
20.6%
1Y
17.8%
Duality Biotherapeutics
Market Cap: HK$18.8b
Duality Biotherapeutics Inc., a clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$213.80
7D
10.0%
1Y
n/a
XtalPi Holdings
Market Cap: HK$18.4b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$4.57
7D
5.8%
1Y
n/a
Shanghai Haohai Biological Technology
Market Cap: HK$11.9b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$27.00
7D
15.1%
1Y
-8.7%
SSY Group
Market Cap: HK$8.9b
An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$3.01
7D
4.2%
1Y
-34.7%
China Shineway Pharmaceutical Group
Market Cap: HK$5.6b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$7.40
7D
3.5%
1Y
-17.4%
VISEN Pharmaceuticals
Market Cap: HK$5.4b
An investment holding company, engages in the development and commercialization of endocrine therapies in the People’s Republic of China, Hong Kong, and Taiwan.
2561
HK$47.50
7D
6.5%
1Y
n/a
AIM Vaccine
Market Cap: HK$5.0b
Researches, develops, manufactures, and commercializes of vaccine products for human use in the People’s Republic of China.
6660
HK$4.06
7D
24.2%
1Y
-45.0%
Beijing Luzhu Biotechnology
Market Cap: HK$4.1b
A biotechnology company, focuses on the research and development, production, and sale of human vaccines and therapeutic biologics to prevent and control infectious diseases, and treat cancer and autoimmune diseases in China.
2480
HK$20.20
7D
-3.8%
1Y
-15.5%
Viva Biotech Holdings
Market Cap: HK$3.6b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.71
7D
-2.8%
1Y
171.4%
Zhejiang Taimei Medical Technology
Market Cap: HK$2.0b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$3.54
7D
1.4%
1Y
n/a
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.6b
A synthetic biology-driven biopharmaceutical company, engages in the research and development, production, and commercialization of oncology products in the People’s Republic of China.
2563
HK$4.41
7D
0%
1Y
n/a
Transcenta Holding
Market Cap: HK$629.0m
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$1.55
7D
44.9%
1Y
-12.4%
Sirnaomics
Market Cap: HK$323.5m
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$3.10
7D
1.6%
1Y
-58.7%